Human Arylamine N-Acetyltransferase 1 (NAT1) Knockout in MDA-MB-231 Breast Cancer Cell Lines Leads to Transcription of NAT2 is a research paper published in Frontiers in Pharmacology (2022). On theSindex it has a DataRank of 0.406. It has been cited 14 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.406
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIGMS NIH HHS
Grant: P20 GM103436
NIGMS NIH HHS
Grant: P30 GM106396
NIEHS NIH HHS
Grant: P30 ES030283
NIEHS NIH HHS
Grant: T32 ES011564
National Institutes of Health
Grant: 3P30ES030283-05S1
University of Louisville Center for Integrative Environmental Health Sciences
National Institutes of Health
Grant: 5T32ES011564-20
UOFL ENVIRONMENTAL HEALTH SCIENCES TRAINING PROGRAM
National Institutes of Health
Grant: 1P30GM106396-01
PILOT PROJECT PROGRAM
National Institutes of Health
Grant: 2P20GM103436-19
IDeA Networks of Biomedical Research Excellence in Kentucky
Fields of Study
Keywords
Sustainable Development Goals